Log In
Print this Print this

Vastiras (Pro ANP 31-67)

  Manage Alerts
Collapse Summary General Information
Company Madeleine Pharmaceuticals
DescriptionLyophilized powder of a linear 37 amino acid atriopeptin peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationCongestive heart failure (CHF)
Indication DetailsTreat congestive heart failure (CHF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today